About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Plaurtm1Mlg
targeted mutation 1, Richard C Mulligan
MGI:1934210
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Plaurtm1Mlg/Plaurtm1Mlg B6.Cg-Plaurtm1Mlg MGI:3527142
hm2
Plaurtm1Mlg/Plaurtm1Mlg involves: 129S2/SvPas * C57BL/6 MGI:3527128


Genotype
MGI:3527142
hm1
Allelic
Composition
Plaurtm1Mlg/Plaurtm1Mlg
Genetic
Background
B6.Cg-Plaurtm1Mlg
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Plaurtm1Mlg mutation (0 available); any Plaur mutation (18 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
N
• in the open-field test, homozygotes display normal generalized motor activity relative to wild-type
• homozygotes exhibit increased susceptibility to pentylenetretrazol (PTZ)-induced seizures, displaying tonic extension and reduced latency time relative to wild-type
• in the open-field paradigm, wild-type mice occupy the margin of the arena for 66% of the time and the center for 34%, whereas mutants occupy the margin area for 76% of the time and the center for 24%, indicating decreased exploratory behavior
• in the light-dark avoidance test, wild-type mice spend ~50% of the 10 min session exploring the lit side of the chamber whereas mutants occupy the lit side for only 25% of the time, preferring the less aversive, dark area
• in the elevated plus maze, wild-type mice spend ~25-30% of the time in the open arms, whereas mutants spend <5% of the time in the open arms; mutants spend >75% of the time in the closed arms, and ~25% of the time in the center of the maze
• ~6% of homozygotes display a novel pattern of spontaneous myoclonic seizures with abnormal bilaterally synchronous interictal discharges during waking behavior; such seizures are occasionally lethal

muscle
• ~6% of homozygotes display a novel pattern of spontaneous myoclonic seizures with abnormal bilaterally synchronous interictal discharges during waking behavior; such seizures are occasionally lethal

nervous system
• homozygotes exhibit increased susceptibility to pentylenetretrazol (PTZ)-induced seizures, displaying tonic extension and reduced latency time relative to wild-type
• ~6% of homozygotes display a novel pattern of spontaneous myoclonic seizures with abnormal bilaterally synchronous interictal discharges during waking behavior; such seizures are occasionally lethal
• at at E16.5 and P0, homozygotes display diminished levels of hepatocyte growth factor/scatter factor (HGF/SF), reduced scatter activity in the forebrain, and impaired migration of interneurons from the ganglionic eminence to the cerebral cortex
• homozygotes display a 50-65% reduction in the number of GABAergic interneurons in frontal and parietal neocortices at E16.5 and P0
• in homozygotes, the cortical plate is well-laminated; however, the overall packing density and thickness of the cerebral wall is greater in mutants compared to wild-type
• adult homozygotes show a 50% deficit in GABA+ cells in both anterior cingulate and parietal cortical regions, with almost complete loss of the parvalbumin subtype
• notably, interneuron numbers in piriform and visual cortical areas remain unaffected
• adult homozygotes exhibit a significant reduction of GABAergic neurons in the parietal cortex, with regional variation in the reduction of GABA+ cells between frontal and visual cortices

cellular
• at at E16.5 and P0, homozygotes display diminished levels of hepatocyte growth factor/scatter factor (HGF/SF), reduced scatter activity in the forebrain, and impaired migration of interneurons from the ganglionic eminence to the cerebral cortex




Genotype
MGI:3527128
hm2
Allelic
Composition
Plaurtm1Mlg/Plaurtm1Mlg
Genetic
Background
involves: 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Plaurtm1Mlg mutation (0 available); any Plaur mutation (18 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
N
• at the age of 4.5 weeks, homozygotes are viable, fertile and display normal growth and histology relative to wild-type mice

hematopoietic system
N
• relative to wild-type, homozygotes exhibit normal spontaneous lysis of 125I-fibrin-labeled pulmonary plasma clots injected via the jugular vein and embolized to the lungs
• 48 hours after intranasal inoculation with S. pneumoniae, homozygotes exhibit reduced neutrophil influx in the bronchoalveolar lavage fluid relative to wild-type mice (J:75573)
• S. pneumoniae-infected lungs display patchy and dense inflammatory infiltrates composed of monocytes and lymphocytes with relatively few granulocytes (J:75573)
• relative to wild-type, purified neutrophils from mutant mice exhibit a ~50% reduction in superoxide production in response to fMLP (a potent chemotaxin and activator of neutrophils) across the entire dose range tested (J:91980)
• in response to fMLP, mutant neutrophils exhibit normal neutrophil exocytosis of azurophilic granules relative to wild-type neutrophils (J:91980)
• also, mutant neutrophils show normal agonist-stimulated release of specific granules relative to wild-type neutrophils (J:91980)
• in vitro, purified neutrophils from mutant mice exhibit a significant reduction in phagocytosis of E. coli at all time points tested
• after intraperitoneal injection of thioglycollate, homozygotes show normal invasion of macrophages into the peritoneal cavity
• in vitro, mutant macrophages degrade extracellular matrix proteins at a similar rate as wild-type mice; however, thioglycollate-stimulated peritoneal macrophages from mutant mice show a 3-fold reduction in the initial rate of u-PA-mediated plasminogen activation

immune system
• 48 hours after intranasal inoculation with S. pneumoniae, homozygotes exhibit reduced neutrophil influx in the bronchoalveolar lavage fluid relative to wild-type mice (J:75573)
• S. pneumoniae-infected lungs display patchy and dense inflammatory infiltrates composed of monocytes and lymphocytes with relatively few granulocytes (J:75573)
• relative to wild-type, purified neutrophils from mutant mice exhibit a ~50% reduction in superoxide production in response to fMLP (a potent chemotaxin and activator of neutrophils) across the entire dose range tested (J:91980)
• in response to fMLP, mutant neutrophils exhibit normal neutrophil exocytosis of azurophilic granules relative to wild-type neutrophils (J:91980)
• also, mutant neutrophils show normal agonist-stimulated release of specific granules relative to wild-type neutrophils (J:91980)
• in vitro, purified neutrophils from mutant mice exhibit a significant reduction in phagocytosis of E. coli at all time points tested
• after intraperitoneal injection of thioglycollate, homozygotes show normal invasion of macrophages into the peritoneal cavity
• in vitro, mutant macrophages degrade extracellular matrix proteins at a similar rate as wild-type mice; however, thioglycollate-stimulated peritoneal macrophages from mutant mice show a 3-fold reduction in the initial rate of u-PA-mediated plasminogen activation
• surprisingly, 48 hours after intranasal inoculation with S. pneumoniae, homozygotes exhibit higher levels of cytokines and chemokines (IL-1beta, IL-6, KC, and CXCL2) in lung homogenates relative to wild-type
• 48 hours after intranasal inoculation with S. pneumoniae, homozygotes exhibit an attenuated antibacterial host defense, with more pneumococci (CFU) in their lungs
• as a result, mutants succumb to pneumococcal pneumonia much earlier than wild-type mice

cardiovascular system
N
• in response to laser-induced injury of the Bruch's membrane, homozygotes display robust choroidal neovascularization at the site of trauma similiar that observed in wild-type mice

homeostasis/metabolism
• surprisingly, 48 hours after intranasal inoculation with S. pneumoniae, homozygotes exhibit higher levels of cytokines and chemokines (IL-1beta, IL-6, KC, and CXCL2) in lung homogenates relative to wild-type

cellular
• in vitro, purified neutrophils from mutant mice exhibit a significant reduction in phagocytosis of E. coli at all time points tested





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory